Acadia Pharmaceuticals (ACAD)'s 30-day implied volatility (IV30) was 42.5% at the close on October 20, 2026, down from 43.7% the day before, against a 52-week range of 23.0% to 114.7%. Its 20-day historical volatility was 43.2%.
Data as of October 20, 2026.